{
  "docId": "019de072-f0cb-7745-907c-f9e6b87d2817",
  "docSlug": "e5afd111c5ca3d26ccce5d5b91b81d60",
  "documentTitle": "BioNTech | Investor Day Presentation Deck | 156 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 93,
  "pageCount": 120,
  "prevPage": 92,
  "nextPage": 94,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a Gantt-style visualization for clinical trial phases.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-f0cb-7745-907c-f9e6b87d2817/93",
  "deckHref": "/decks/019de072-f0cb-7745-907c-f9e6b87d2817",
  "deckJsonHref": "/decks/019de072-f0cb-7745-907c-f9e6b87d2817.json",
  "deckAnchorHref": "/decks/019de072-f0cb-7745-907c-f9e6b87d2817#slide-93",
  "components": [
    {
      "bbox": {
        "h": 0.68,
        "w": 0.175,
        "x": 0.625,
        "y": 0.23
      },
      "kind": "chart",
      "text": "Clinical trial phase progress bars",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9f17d829-ce83-448b-9913-0533de8a2ad1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.51,
        "x": 0.048,
        "y": 0.092
      },
      "kind": "disclaimer",
      "text": "SMIM, small molecule immunomodulators. 1 Investigator-initiated Phase 1 trial; 2 Collaboration with Genentech; 3 Collaboration with Sanofi; 4 Collaboration with Genmab.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3af2fcae-e09d-4050-b1db-56067c55b691",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.78,
        "w": 0.905,
        "x": 0.048,
        "y": 0.0011799999999999998
      },
      "kind": "table",
      "text": "Pipeline table with columns: Drug class, Platform, Product candidate, Indication, Clinical phases, Milestones",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5eec3e32-4f4e-4eca-af71-098e335ca2b3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.038,
        "w": 0.785,
        "x": 0.048,
        "y": 0.105
      },
      "kind": "title",
      "text": "Oncology pipeline: Significant progress and expansion in 2022",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b15c2ef6-b709-4016-aa36-81b9067936d4",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "842293df-bb45-4bfe-b4b1-f7da88737a0a",
      "evidence": "The clinical trial phases are represented as horizontal bars indicating duration/status.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 120,
      "from": 91,
      "beatId": "bf198718-eb7f-470f-aca0-0f710fbb4f37",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Product Pipeline",
      "beatSlug": "sequoia-pitch-product",
      "evidence": "The presentation showcases BioNTech's product pipeline, including its oncology and infectious disease programs",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}